Fatemeh Kaveh
- Postdoc; PhD, MSc
- +47 22 78 23 19
NFR CellFit
Education:
2008 – 2013: PhD in Bioinformatics – Genetics, Genomics signatures in progression of breast cancer with reference to gynecological carcinomas, Faculty of Medicine,University of Oslo, Norway.
2005 – 2007: Master of Science in Bioinformatics and System Biology, Department of Mathematics, Chalmers University, Göteborg, Sweden.
1994 – 1999: Bachelor of Science in Medical Engineering (Bio-Electric), Azad University, Tehran, Iran.
Work experience:
03/2022 – Present: Postdoc, Department of Cellular Therapy, OUS-Radiumhospitalet, Oslo, Norway.
2018 – 2021: Postdoc, BigMed Project (RNA-Seq pipeline), Department of Tumor Biology, OUS-Radiumhospitalet, Oslo, Norway.
2013 – 2018: Postdoc, Qualitative and quantitative HLA data from next generation sequencing, Department of Medicine Genetics, OUS-Ullevål hospital, Oslo, Norway.
05/2015 – 11/2015: Postdoc, Whole genome and exome sequencing of childhood cancer, Department of Pediatric Research, Women and Children's Division, Rikshospitalet, Oslo, Norway.
2008 – 2013: PhD Student (Research), analysis of whole genome variation (SNPs & CNVs) in relation to the risk and progression of breast cancer with reference to gynecological carcinomas, Institute of cancer research, Department of Genetics, OUS-Radiumhospitalet, Oslo, Norway.
2006 – 2007: Research (Master thesis), Non-coding RNAs, Lundberg Laboratory, Göteborg University, Göteborg, Sweden.
2000 – 2003: Engineer in Design and Research Centre, Iran Six Star Co., Tehran, Iran.
1999 – 2000: Medical Engineer, Mofid Hospital, Tehran, Iran.
1998 – 1999: Research (bachelor thesis), eliminating noise from EEG signals in the Neurology department of Shohadaye Tajrish Hospital, Tehran, Iran.
1997 – 1998: Engineer, Electronic factory, Tehran, Iran.
Research interests/projects:
Bioinformatics (RNA-seq, whole-genome and targeted sequencing in cancer research), statistical analysis, machine learning
Publications 2021
The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology
J. Pers. Med., 11 (5), 330
DOI 10.3390/jpm11050330
Publications 2020
Loss of Snord116 impacts lateral hypothalamus, sleep, and food-related behaviors
JCI Insight, 5 (12), e137495
DOI 10.1172/jci.insight.137495
Publications 2018
A systematic comparison of copy number alterations in four types of female cancer (vol 16, 913, 2016)
BMC Cancer, 18
DOI 10.1186/s12885-017-3766-7
Publications 2017
Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease
J. Hepatol., 66 (1), 116-122
DOI 10.1016/j.jhep.2016.09.002
Publications 2016
A Cross-Sectional Study of the Prevalence of Gastrointestinal Symptoms and Pathology in Patients With Common Variable Immunodeficiency
Am. J. Gastroenterol., 111 (10), 1467-1475
DOI 10.1038/ajg.2016.329
A systematic comparison of copy number alterations in four types of female cancer
BMC Cancer, 16, 913
DOI 10.1186/s12885-016-2899-4
High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
Hepatology, 63 (5), 1608-1619
DOI 10.1002/hep.28116
Publications 2015
Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
Breast Cancer Res., 17, 44
DOI 10.1186/s13058-015-0548-5
Publications 2011
Allele-specific disparity in breast cancer
BMC Med. Genomics, 4, 85
DOI 10.1186/1755-8794-4-85